Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000644337 | SCV000766030 | likely benign | Tuberous sclerosis 2 | 2024-09-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001013956 | SCV001174602 | likely benign | Hereditary cancer-predisposing syndrome | 2022-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000644337 | SCV002039603 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000644337 | SCV005403538 | likely benign | Tuberous sclerosis 2 | 2024-08-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
All of Us Research Program, |
RCV004802337 | SCV005427121 | uncertain significance | Tuberous sclerosis syndrome | 2024-04-10 | criteria provided, single submitter | clinical testing |